329 related articles for article (PubMed ID: 19535207)
1. Diabetes and the menopause.
Wedisinghe L; Perera M
Maturitas; 2009 Jul; 63(3):200-3. PubMed ID: 19535207
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal hormone therapy and the risk of cardiovascular disease.
Stramba-Badiale M
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
[TBL] [Abstract][Full Text] [Related]
4. Menopause management: a cardiovascular risk-based approach.
Haines CJ; Farrell E
Climacteric; 2010 Aug; 13(4):328-39. PubMed ID: 20001565
[TBL] [Abstract][Full Text] [Related]
5. [Cardiovascular risk after menopause].
Grand A
Ann Cardiol Angeiol (Paris); 1992 Mar; 41(3):151-61. PubMed ID: 1610097
[TBL] [Abstract][Full Text] [Related]
6. Sex hormones and the cardiovascular system: effects on arterial function in women.
Teede HJ
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):672-6. PubMed ID: 17581228
[TBL] [Abstract][Full Text] [Related]
7. Diabetes and the menopause. Special considerations.
Phillips P
Aust Fam Physician; 1998; 27(1-2):59-63. PubMed ID: 9503708
[TBL] [Abstract][Full Text] [Related]
8. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention.
Vitale C; Miceli M; Rosano GM
Climacteric; 2007 Oct; 10 Suppl 2():16-20. PubMed ID: 17882667
[TBL] [Abstract][Full Text] [Related]
9. Hormone therapy for menopausal women.
Holcomb SS
Nurse Pract; 2009 Dec; 34(12):9-11. PubMed ID: 19952580
[No Abstract] [Full Text] [Related]
10. Managing cardiovascular risk in menopausal women.
Rosano GM; Vitale C; Tulli A
Climacteric; 2006 Sep; 9 Suppl 1():19-27. PubMed ID: 16899440
[TBL] [Abstract][Full Text] [Related]
11. Consequences of menopause in women with diabetes mellitus - a clinical problem.
Jedrzejuk D; Milewicz A
Gynecol Endocrinol; 2005 Nov; 21(5):280-6. PubMed ID: 16373247
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy in postmenopausal women with diabetes mellitus.
Thijs A; Stehouwer CD
Semin Vasc Med; 2002 May; 2(2):215-9. PubMed ID: 16222612
[TBL] [Abstract][Full Text] [Related]
13. Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene.
Wenger NK; Geiger MJ
Contemp Clin Trials; 2005 Dec; 26(6):612-5. PubMed ID: 16257585
[TBL] [Abstract][Full Text] [Related]
14. [Hormone replacement therapy and cardiovascular risk in postmenopausal women].
Kovacev-Zavisić B; Icin T; Kovacev N
Med Pregl; 2009; 62 Suppl 3():85-90. PubMed ID: 19702123
[TBL] [Abstract][Full Text] [Related]
15. Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists.
Collins P; Rosano G; Casey C; Daly C; Gambacciani M; Hadji P; Kaaja R; Mikkola T; Palacios S; Preston R; Simon T; Stevenson J; Stramba-Badiale M
Eur Heart J; 2007 Aug; 28(16):2028-40. PubMed ID: 17644507
[TBL] [Abstract][Full Text] [Related]
16. The medical management of menopause: to treat or not to treat?
Barlow DH
Ann N Y Acad Sci; 2008 Apr; 1127():134-9. PubMed ID: 18443341
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy post Women's Health Initiative study: where do we stand?
Calleja-Agius J; Brincat MP
Curr Opin Obstet Gynecol; 2008 Dec; 20(6):513-8. PubMed ID: 18989125
[TBL] [Abstract][Full Text] [Related]
18. [Should all menopausal women have hormone replacement therapy for the prevention of coronary disease?].
Neves-e-Castro M
Rev Port Cardiol; 1999 Nov; 18(11):1039-43. PubMed ID: 10608164
[TBL] [Abstract][Full Text] [Related]
19. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
20. Menopause: developing a rational treatment plan.
Vitiello D; Naftolin F; Taylor HS
Gynecol Endocrinol; 2007 Dec; 23(12):682-91. PubMed ID: 18075843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
